Bionure

MainImage

1,100,246.05€

Out of 960,000.00€

investors

259

Est. ROI

1400%

days left

2

BN201: Primer fármaco de la historia Neuroprotector y Regenerador de la Mielina para tratar la Esclerosis Múltiple

Finish date: 31/03/2017 Barcelona

Premoney valuation

9,400,000.00€

Percentage offered

9.27%

Est. ROI

1400%

Exit horizon

2019